Selecting a precursor ion focuses the experiment on one mass-to-charge feature rather than the entire ion mixture. That ion is then subjected to collision-induced dissociation, producing product ions derived from it. Comparing the resulting pattern with the precursor measurement helps connect a molecular signal to structural or sequence information, which is especially useful for peptides and other biomolecules.
Collision-induced dissociation is the step that converts an isolated precursor into a set of product ions. The collection of fragments carries more interpretive information than the precursor mass alone because their pattern can reflect molecular structure and sequence. In biological analysis, this distinction supports characterization of peptides, proteins, metabolites, and molecules bearing post-translational modifications.
For peptides, product-ion patterns provide fragment-level evidence that can be related to sequence. Changes associated with post-translational modifications can also be mapped through the fragment information. This makes the analysis more informative than reporting only a molecule’s overall mass, supporting protein identification and characterization in proteomics.
A typical workflow begins by ionizing compounds, separating ions according to mass-to-charge ratio, and isolating a precursor ion. Collision-induced dissociation then generates product ions, whose measured pattern is interpreted for molecular structure or sequence. When liquid chromatography is included, it forms part of the broader analytical workflow for complex biological samples.
Liquid chromatography is often used alongside MS/MS analysis when biological samples contain complex mixtures. Its inclusion places the mass-spectrometric measurements within a broader separation-and-analysis workflow, allowing molecular signals to be examined in samples where many compounds are present. This combination is particularly relevant to proteomic and metabolomic studies of biological material.
MS/MS analysis can help investigate cellular pathways, disease-associated molecular changes, and biochemical interactions. It does so by providing evidence tied to particular peptides, proteins, metabolites, or modified molecules rather than only broad sample-level patterns. Consequently, researchers can use the measurements in proteomics and metabolomics to identify molecules and quantify or characterize them in biological studies.